Skip to content
Tuesday 11 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,835.04
-0.25%
DAX
26,265.63
-0.22%
CAC 40
8,705.65
-0.23%
STOXX 50
6,535.19
-0.01%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Tuesday 30 September 2014 5:20 pm  |  Updated:  Friday 07 June 2019 11:47 am

Ebola virus diagnosed in the US: Tekmiara share price surges as first case confirmed by CDC in Dallas, Texas

By: Lynsey Barber

Add as a preferred source on Google

The first case of the deadly Ebola virus to be diagnosed outside of Africa has been confirmed in a patient in the US.

The unnamed man was admitted to a hospital in Dallas, Texas with symptoms of the disease and isolated on Sunday after returning from West Africa the US Centre for Disease Control (CDC) has confirmed.

A number of US citizen’s have been infected with the deadly virus and later been flown back to the country for treatment, however, it’s the first time a patient has become unknowingly infected and later diagnosed within the borders of the US, or outside of Africa.

The news sent shares in Tekmira soaring more than 20 per cent in after hours trading. The Canadian drugmaker is one of a number of pharmaceutical firms, including GSK, Mapp and Fujifilm working on a cure for the deadly disease.

The infected patient traveled from Liberia where there have been more than 1,500 cases and more than 800 deaths from the virus.

The patient left Liberia on 19 September, arriving in the US on 20 September and began to develop symptoms on 27 Septemeber.

The CDC believes no other passengers have been put at risk as the patient did not have any symptoms at the time of traveling.

It's believed to be the first case of this strain of the Ebola outbreak outside of Africa.

The World Health Organisation warned at the beginning of September that the disease was spreading “exponentially” in Liberia which has been hardest hit by the outbreak, and that thousands risked becoming infected.

According to a new study of the disease, the risk of Ebola being carried to the US is between one and 18 per cent.

Outside of Africa where the current outbreak has killed more than 3,000 people, the UK and Belgium were found to be more at risk of importing a case than the US.

A statement from the Texas department of health said:

The patient developed symptoms days after returning to Texas from West Africa and was admitted into isolation on Sunday at Texas Health Presbyterian Hospital in Dallas.

The Texas Department of State Health Services is working with the CDC, the local health department and the hospital to investigate the case and work to prevent transmission of the disease. The hospital has implemented infection control measures to help ensure the safety of patients and staff.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Ebola

Trending Articles

  • Nottingham Forest owner Marinakis sues Crystal Palace for defamation

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • Hargreaves Lansdown orders staff back to office

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • As it happened: Intel, Arm shares slide; Oil climbs higher

More from Morning Wire

  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • PwC sign sponsorship deal with major cricket team

    Sport Business
    Getty Images logo on a modern office building facade under a clear blue sky, representing media and photography industry p...
  • Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

    Business Wire
  • ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Business Wire
  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
  • Miami heat: Why climate could be key in 40C England v Norway World Cup quarter-final

    Sport Business
    Business professionals discussing strategies in a modern office setting with charts and graphs on a large screen in the ba...
  • How patient can the Bank of England be?

    AD
    Historic Royal Exchange building in London with modern skyscrapers behind, clear blue sky.
  • Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook